{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:06:21Z","timestamp":1789139181021,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1195830"],"award-info":[{"award-number":["1195830"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Patients with Parkinson\u2019s disease (PD) and atypical parkinsonian syndromes are at increased risk of falls and should be actively screened and treated for osteoporosis. In 2024, the Royal Australian College of General Practitioners (RACGP) revised their practice guidelines for diagnosing and managing osteoporosis in postmenopausal women and men aged over 50\u00a0years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>We conducted the first Australian study to audit these guidelines in patients with PD and atypical parkinsonian syndromes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>We audited all PD, Dementia with Lewy Bodies, Progressive Supranuclear Palsy and Multiple System Atrophy cases attending our neurology service between January and March 2024 against the RACGP osteoporosis guidelines. We identified patients at risk of osteoporosis or minimal trauma fractures and assessed if they had been referred to their general practitioner (GP) for appropriate management or were already receiving appropriate osteoporosis treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>This audit evaluated 230 patients, 199 of which had PD. We identified 78 patients over the age of 50\u00a0years with risk factors that should trigger a GP bone health assessment as per the guidelines. Twenty-six of these patients were already being managed appropriately. However, only 12 of the remaining 52 \u2018at risk\u2019 patients (23%) were directed to seek screening for osteoporosis by their GP, leaving 77% (40\/52) without appropriate guidance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our major recommendations include following the guidelines and referring patients for a bone health screen with their GP if they have risk factors for osteoporosis. This audit highlighted that assessment of osteoporosis and fracture risk by Specialists needs to be improved.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00415-024-12752-z","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T13:28:46Z","timestamp":1736947726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An audit on the assessment and management of osteoporosis in a Parkinson\u2019s and related diseases clinic in Australia"],"prefix":"10.1007","volume":"272","author":[{"given":"Nethmi Nuwanji","family":"Amarasekera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Coppin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4093-7071","authenticated-orcid":false,"given":"Simon J. G.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"12752_CR1","unstructured":"Australia Healthy Bones (2024) Osteoporosis management and fracture prevention in postmenopausal women and men over 50 years of age. The Royal Australian College of General Practitioners. https:\/\/www.racgp.org.au\/getattachment\/4679d28b-5096-44ef-97bb-71ac2b14fa3c\/Osteoporosis-management-and-fracture-prevention-in-post-menopausal-women-and-men-50-years-of-age.aspx. Viewed May 2024"},{"key":"12752_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.parkreldis.2019.03.021","volume":"64","author":"EJ Henderson","year":"2019","unstructured":"Henderson EJ, Lyell V, Bhimjiyani A et al (2019) Management of fracture risk in Parkinson\u2019s: a revised algorithm and focused review of treatments. Parkinsonism Relat Disord 64:181\u2013187","journal-title":"Parkinsonism Relat Disord"},{"key":"12752_CR3","first-page":"16","volume":"8","author":"LM Raglione","year":"2011","unstructured":"Raglione LM, Sorbi S, Nacmias B (2011) Osteoporosis and Parkinson\u2019s disease. Clin Cases Miner Bone Metab 8:16\u201318","journal-title":"Clin Cases Miner Bone Metab"},{"key":"12752_CR4","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/jnnp-2013-307307","volume":"85","author":"KM Torsney","year":"2014","unstructured":"Torsney KM, Noyce AJ, Doherty KM et al (2014) Bone health in Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 85:1159\u20131166","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12752_CR5","unstructured":"Parkinsons Excellence Network (2024) Bone health improvement in Parkinson\u2019s\u2014phase 2 report. Parkinsons UK: Better Bone Health Resources. https:\/\/www.parkinsons.org.uk\/sites\/default\/files\/2024-04\/Bone%20Health%20Improvement%20Phase%202%20report%20PDF%20206KB.pdf. Viewed May 2024"},{"key":"12752_CR6","unstructured":"Sacha Gandhi DFS, Steven W (2022) Osteoporosis in degenerative parkinsonism. Parkinson\u2019s Academy: falls and bone health. https:\/\/neurologyacademy.org\/parkinsons-academy\/projects\/osteoporosis-in-degenerative-parkinsonism. Viewed May 2024"},{"key":"12752_CR7","unstructured":"National Osteoporosis Guideline Group UK (2021) Clinical guideline for the prevention and treatment of osteoporosis 2021. National Osteoporosis Guideline Group UK. https:\/\/www.nogg.org.uk\/full-guideline. Viewed May 2024"},{"key":"12752_CR8","unstructured":"UK Parkinson\u2019s Excellence Network (2020) 2019 UK Parkinson\u2019s Audit Summary report. Parkinson\u2019s UK. https:\/\/www.parkinsons.org.uk\/sites\/default\/files\/2020-01\/CS3524%20Parkinson%27s%20UK%20Audit%20-%20Summary%20Report%202019%20%281%29.pdf. Viewed May 2024"},{"key":"12752_CR9","unstructured":"UK Parkinson\u2019s Excellence Network (2023) 2022 UK Parkinson\u2019s Audit Summary report. Parkinson\u2019s UK. https:\/\/www.parkinsons.org.uk\/sites\/default\/files\/2023-06\/2022%20Summary%20Report%20-%20FINAL.pdf. Viewed May 2024"},{"key":"12752_CR10","unstructured":"UK Parkinson\u2019s Excellence Network (2022) Better bone health service improvement project. Parkinson\u2019s UK: Better Bone Health resources. https:\/\/www.parkinsons.org.uk\/sites\/default\/files\/2022-08\/CS3897%20Excellence%20Network%20audit%20report%20covers_final%20%281%29.pdf. Viewed May 2024"},{"key":"12752_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjquality.u210921.w5756","author":"I Singh","year":"2016","unstructured":"Singh I, Fletcher R, Scanlon L et al (2016) A quality improvement initiative on the management of osteoporosis in older people with Parkinsonism. BMJ Qual Improv Rep. https:\/\/doi.org\/10.1136\/bmjquality.u210921.w5756","journal-title":"BMJ Qual Improv Rep"},{"key":"12752_CR12","unstructured":"Beatriz C. Analysis of pharmacology and osteoporotic fracture prevalence in Lincolnshire patients with Parkinson\u2019s disease: bone protection, anticholinergic burden and polypharmacy. Falls and bone health. https:\/\/neurologyacademy.org\/parkinsons-academy\/projects\/analysis-of-pharmacology-and-osteoporotic-fracture-prevalence-in-lincolnshire-patients-with-parkinsons-disease-bone-protection-anticholinergic-burden-and-polypharmacy. Viewed May 2024"},{"key":"12752_CR13","unstructured":"Osteoporosis Australia (2017) Osteoporosis prevention, diagnosis and management post-menopausal women and men over 50 years of age, 2nd edition. Royal Australian College of General Practitioners. https:\/\/healthybonesaustralia.org.au\/wp-content\/uploads\/2022\/12\/oa-racgp-osteoporosis-clinical-guidelines-2nd-ed.pdf. Viewed May 2024"},{"key":"12752_CR14","first-page":"61","volume":"113","author":"J Levin","year":"2016","unstructured":"Levin J, Kurz A, Arzberger T et al (2016) The differential diagnosis and treatment of atypical parkinsonism. Dtsch Arztebl Int 113:61\u201369","journal-title":"Dtsch Arztebl Int"},{"key":"12752_CR15","unstructured":"Julia CG, Roger AB (2018) The differential diagnosis of parkinson\u2019s disease. In: Stoker TBGJ (ed) Parkinson\u2019s disease: pathogenesis and clinical aspects. Codon Publications, Brisbane"},{"key":"12752_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676","journal-title":"Neurology"},{"key":"12752_CR17","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864","journal-title":"Mov Disord"},{"key":"12752_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14802\/jmd.19052","volume":"13","author":"M Yamada","year":"2020","unstructured":"Yamada M, Komatsu J, Nakamura K et al (2020) Diagnostic criteria for dementia with lewy bodies: updates and future directions. J Mov Disord 13:1\u201310","journal-title":"J Mov Disord"},{"key":"12752_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/906274","author":"NE Allen","year":"2013","unstructured":"Allen NE, Schwarzel AK, Canning CG (2013) Recurrent falls in Parkinson\u2019s disease: a systematic review. Parkinsons Dis. https:\/\/doi.org\/10.1155\/2013\/906274","journal-title":"Parkinsons Dis"},{"issue":"7","key":"12752_CR20","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mds.29410","volume":"38","author":"ST Jost","year":"2023","unstructured":"Jost ST, Kaldenbach MA, Antonini A, Martinez-Martin P, Timmermann L, Odin P et al (2023) Levodopa dose equivalency in Parkinson\u2019s disease: updated systematic review and proposals. Mov Disord 38(7):1236\u20131252","journal-title":"Mov Disord"},{"key":"12752_CR21","first-page":"423","volume":"42","author":"D Parker","year":"2013","unstructured":"Parker D (2013) An audit of osteoporotic patients in an Australian general practice. Aust J Gen Pract 42:423\u2013427","journal-title":"Aust J Gen Pract"},{"key":"12752_CR22","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.5694\/j.1326-5377.2004.tb05908.x","volume":"180","author":"TV Nguyen","year":"2004","unstructured":"Nguyen TV, Center JR, Eisman JA (2004) Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust 180:S18-22","journal-title":"Med J Aust"},{"key":"12752_CR23","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1359\/jbmr.040905","volume":"19","author":"J Eisman","year":"2004","unstructured":"Eisman J, Clapham S, Kehoe L (2004) Osteoporosis prevalence and levels of treatment in primary care: the Australian Bone Care Study. J Bone Miner Res 19:1969\u20131975","journal-title":"J Bone Miner Res"},{"issue":"5","key":"12752_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.14740\/jocmr2970w","volume":"9","author":"KA Alswat","year":"2017","unstructured":"Alswat KA (2017) Gender disparities in osteoporosis. J Clin Med Res 9(5):382\u2013387","journal-title":"J Clin Med Res"},{"issue":"3","key":"12752_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri S, Mus L, Blandini F (2019) Parkinson\u2019s disease in women and men: what\u2019s the difference? J Parkinsons Dis 9(3):501\u2013515","journal-title":"J Parkinsons Dis"},{"key":"12752_CR26","unstructured":"Susan P (1998) Hereditary ataxia overview. Gene Rev"},{"key":"12752_CR27","doi-asserted-by":"publisher","first-page":"108181","DOI":"10.1016\/j.clineuro.2024.108181","volume":"239","author":"F Zhang","year":"2024","unstructured":"Zhang F, Lu J, Zhang Y, Liu J (2024) Significance of non-motor symptoms and development of a screening tool for osteoporosis in Parkinson\u2019s disease. Clin Neurol Neurosurg 239:108181","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12752-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12752-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12752-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T16:42:12Z","timestamp":1739637732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12752-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["12752"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12752-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical compliance and consent to participate"}}],"article-number":"139"}}